[
1. WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/. (accesed March 10, 2022)
]Search in Google Scholar
[
2. CDC. SARS-CoV-2 Variant Classifications and Definitions. Accesed February 9, 2022. https://www.cdc.gov/
]Search in Google Scholar
[
3. WHO. Classification of Omicron (B.1.1.529): SARSCoV-2 Variant of Concern. Accessed December 26, 2021. https://www.who.int/news/item/26-12-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern
]Search in Google Scholar
[
4. ECDC. European Centre for Disease Prevention and Control. Epidemiological update: Omicron variant of concern (VOC)data as of 16 December 2021 (12.00); 2021. https://www.ecdc.europa.eu/en/news-events/epidemiological-update-omicron-data-16-december
]Search in Google Scholar
[
5. Cross R. Omicron puts scientists on red alert. Chem Eng News. 2021;99:44.
]Search in Google Scholar
[
6. Chen J, Wang R, Gilby NB, Wei GW. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. ArXiv. 2021.10.1021/acs.jcim.1c01451875164534989238
]Search in Google Scholar
[
7. Islam R, Hossain J. Detection of Omicron (B.1.1.529) variant has created panic among the people across the world: what should we do right now? J Med Virol. 2022. doi:10.1002/jmv.2754634939691
]Open DOISearch in Google Scholar
[
8. Metzger C, Lienhard R, Seth-Smith H, et al. PCR performance in the SARS-CoV-2 Omicron variant of concern? Swiss Med Wkly. 2021;151:w30120. doi:10.4414/smw.2021.w3012034909869
]Open DOISearch in Google Scholar
[
9. Iacobucci G. Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. BMJ. 2021;375:n3103. doi:10.1136/bmj.n310334916215
]Open DOISearch in Google Scholar
[
10. Jiahui Chen, Rui Wang, Nancy Benovich Gilby, and Guo-Wei Wei. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. Journal of Chemical Information and Modeling. 2022; 62 (2), 412-422.
]Search in Google Scholar
[
11. N.C. Wu, M. Yuan, H. Liu, C.D. Lee, X. Zhu, S. Bangaru, et al. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. bioRxiv (2020).
]Search in Google Scholar
[
12. Giri, S., Sen, S., Singh, R. et al. Current challenges in different approaches to control COVID-19: a comprehensive review. Bull Natl Res Cent 46, 47 (2022).10.1186/s42269-022-00730-2889240535261539
]Search in Google Scholar
